Logo image of MYPS

PLAYSTUDIOS INC (MYPS) Stock Fundamental Analysis

NASDAQ:MYPS - Nasdaq - US72815G1085 - Common Stock - Currency: USD

1.05  -0.02 (-1.87%)

After market: 1.06 +0.01 (+0.95%)

Fundamental Rating

4

Taking everything into account, MYPS scores 4 out of 10 in our fundamental rating. MYPS was compared to 73 industry peers in the Entertainment industry. MYPS has a great financial health rating, but its profitability evaluates not so good. MYPS has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year MYPS has reported negative net income.
In the past year MYPS had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: MYPS reported negative net income in multiple years.
Each year in the past 5 years MYPS had a positive operating cash flow.
MYPS Yearly Net Income VS EBIT VS OCF VS FCFMYPS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

Looking at the Return On Assets, with a value of -9.88%, MYPS is doing worse than 65.75% of the companies in the same industry.
With a Return On Equity value of -12.70%, MYPS perfoms like the industry average, outperforming 52.05% of the companies in the same industry.
Industry RankSector Rank
ROA -9.88%
ROE -12.7%
ROIC N/A
ROA(3y)-6.41%
ROA(5y)-1.3%
ROE(3y)-8.11%
ROE(5y)-1.5%
ROIC(3y)N/A
ROIC(5y)N/A
MYPS Yearly ROA, ROE, ROICMYPS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

Looking at the Gross Margin, with a value of 74.65%, MYPS belongs to the top of the industry, outperforming 89.04% of the companies in the same industry.
MYPS's Gross Margin has improved in the last couple of years.
MYPS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 74.65%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.2%
GM growth 5Y2.4%
MYPS Yearly Profit, Operating, Gross MarginsMYPS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

9

2. Health

2.1 Basic Checks

MYPS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, MYPS has less shares outstanding
MYPS has less shares outstanding than it did 5 years ago.
MYPS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MYPS Yearly Shares OutstandingMYPS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
MYPS Yearly Total Debt VS Total AssetsMYPS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

An Altman-Z score of 2.20 indicates that MYPS is not a great score, but indicates only limited risk for bankruptcy at the moment.
MYPS has a better Altman-Z score (2.20) than 69.86% of its industry peers.
MYPS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 2.2
ROIC/WACCN/A
WACC8.91%
MYPS Yearly LT Debt VS Equity VS FCFMYPS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

MYPS has a Current Ratio of 3.60. This indicates that MYPS is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.60, MYPS belongs to the top of the industry, outperforming 91.78% of the companies in the same industry.
MYPS has a Quick Ratio of 3.60. This indicates that MYPS is financially healthy and has no problem in meeting its short term obligations.
MYPS's Quick ratio of 3.60 is amongst the best of the industry. MYPS outperforms 91.78% of its industry peers.
Industry RankSector Rank
Current Ratio 3.6
Quick Ratio 3.6
MYPS Yearly Current Assets VS Current LiabilitesMYPS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

2

3. Growth

3.1 Past

MYPS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -71.43%.
MYPS shows a decrease in Revenue. In the last year, the revenue decreased by -6.90%.
Measured over the past years, MYPS shows a small growth in Revenue. The Revenue has been growing by 3.87% on average per year.
EPS 1Y (TTM)-71.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)-6.9%
Revenue growth 3Y0.23%
Revenue growth 5Y3.87%
Sales Q2Q%-18.25%

3.2 Future

The Earnings Per Share is expected to grow by 31.72% on average over the next years. This is a very strong growth
Based on estimates for the next years, MYPS will show a decrease in Revenue. The Revenue will decrease by -5.05% on average per year.
EPS Next Y77.98%
EPS Next 2Y39.61%
EPS Next 3Y31.72%
EPS Next 5YN/A
Revenue Next Year-11.99%
Revenue Next 2Y-5.77%
Revenue Next 3Y-2.88%
Revenue Next 5Y-5.05%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MYPS Yearly Revenue VS EstimatesMYPS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M
MYPS Yearly EPS VS EstimatesMYPS Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 -0.1 -0.2

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

MYPS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year MYPS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MYPS Price Earnings VS Forward Price EarningsMYPS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 200

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MYPS is valued cheaply inside the industry as 97.26% of the companies are valued more expensively.
MYPS's Price/Free Cash Flow ratio is rather cheap when compared to the industry. MYPS is cheaper than 94.52% of the companies in the same industry.
Industry RankSector Rank
P/FCF 5.42
EV/EBITDA 0.77
MYPS Per share dataMYPS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

MYPS's earnings are expected to grow with 31.72% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.61%
EPS Next 3Y31.72%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MYPS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PLAYSTUDIOS INC

NASDAQ:MYPS (8/8/2025, 8:00:02 PM)

After market: 1.06 +0.01 (+0.95%)

1.05

-0.02 (-1.87%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)08-04 2025-08-04/amc
Earnings (Next)N/A N/A
Inst Owners37.99%
Inst Owner Change0%
Ins Owners3.2%
Ins Owner Change2.05%
Market Cap132.19M
Analysts78.18
Price Target2.93 (179.05%)
Short Float %0.48%
Short Ratio1.33
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-62.71%
Min EPS beat(2)-110.08%
Max EPS beat(2)-15.34%
EPS beat(4)1
Avg EPS beat(4)-37.37%
Min EPS beat(4)-110.08%
Max EPS beat(4)17.72%
EPS beat(8)4
Avg EPS beat(8)-57.28%
EPS beat(12)8
Avg EPS beat(12)90.29%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.88%
Min Revenue beat(2)-4.32%
Max Revenue beat(2)-1.44%
Revenue beat(4)1
Avg Revenue beat(4)-2.32%
Min Revenue beat(4)-5.33%
Max Revenue beat(4)1.83%
Revenue beat(8)3
Avg Revenue beat(8)-1.65%
Revenue beat(12)6
Avg Revenue beat(12)0.28%
Revenue beat(16)7
Avg Revenue beat(16)-0.26%
PT rev (1m)0%
PT rev (3m)1.47%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-12.07%
EPS NY rev (1m)0%
EPS NY rev (3m)-90%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.49%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.11%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.48
P/FCF 5.42
P/OCF 3
P/B 0.54
P/tB 1.26
EV/EBITDA 0.77
EPS(TTM)-0.24
EYN/A
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)0.19
FCFY18.46%
OCF(TTM)0.35
OCFY33.32%
SpS2.18
BVpS1.94
TBVpS0.83
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.88%
ROE -12.7%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 74.65%
FCFM 8.9%
ROA(3y)-6.41%
ROA(5y)-1.3%
ROE(3y)-8.11%
ROE(5y)-1.5%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.2%
GM growth 5Y2.4%
F-Score5
Asset Turnover0.87
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 45.13%
Cap/Sales 7.16%
Interest Coverage N/A
Cash Conversion 122.3%
Profit Quality N/A
Current Ratio 3.6
Quick Ratio 3.6
Altman-Z 2.2
F-Score5
WACC8.91%
ROIC/WACCN/A
Cap/Depr(3y)71.79%
Cap/Depr(5y)97.26%
Cap/Sales(3y)9.92%
Cap/Sales(5y)10.8%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-71.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y77.98%
EPS Next 2Y39.61%
EPS Next 3Y31.72%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.9%
Revenue growth 3Y0.23%
Revenue growth 5Y3.87%
Sales Q2Q%-18.25%
Revenue Next Year-11.99%
Revenue Next 2Y-5.77%
Revenue Next 3Y-2.88%
Revenue Next 5Y-5.05%
EBIT growth 1Y-55.63%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year315.5%
EBIT Next 3Y65.75%
EBIT Next 5Y49.12%
FCF growth 1Y428.94%
FCF growth 3YN/A
FCF growth 5Y16.46%
OCF growth 1Y67.52%
OCF growth 3Y10.52%
OCF growth 5Y4.85%